Content labelled as: MS news

MS drug hope

Blog post

Source BBC: MS drug hope for secondary-progressive stage. A study of a new drug to treat advanced cases of multiple sclerosis suggests it may be possible to delay progression of the disease in the short term, although the effects were small.

Caroline Wyatt - My quest to stop MS in its tracks

Blog post

Source BBC: A year on from gruelling stem cell treatment for her multiple sclerosis, BBC correspondent Caroline Wyatt reveals what effect the potentially life-changing "reboot" of her immune system has had on her life.

Daclizumab withdrawn from NHS after safety concerns

Blog post

Source MS Society:

Disease modifying therapy daclizumab (Zinbryta) has been withdrawn from sale worldwide. Its manufacturers took the decision after reports that a number of people taking the treatment developed serious inflammatory brain disorders.

Want to try Hydrotherapy?

Blog post

Hydrotherapy is physiotherapy in a warm water pool. A physiotherapist works with you as you gently exercise in the pool.

Are you tripping up more than usual?

Blog post

Are you tripping up more than usual? It could be an MS symptom called foot drop, which is caused by weakness in the ankle or disruption in the nerve pathway between the legs and the brain.

Men hold secret to protect women from multiple sclerosis

Blog post

Source EurekAlert:

Guardian molecule induced by testosterone reverses harmful immune response, eliminates disease symptoms in female mice.

NICE proposes rejecting five drugs for relapsing MS - MS Trust responds

Blog post

Source MS Trust:

NICE has recommended Extavia, but rejected Copaxone, Avonex, Betaferon, Plegridy and Rebif in its preliminary appraisal of MS drugs. The MS Trust has responded to NICE’s consultation in the strongest possible terms.

PIPs: What next for benefit claimants?

Blog post

Source BBC:

BMSTC Member Sue Doughty is mentioned in the article - "Sue Doughty lives in Twyford, Berkshire. She has multiple sclerosis. She faced homelessness and had to rely on help from her daughter.

Following a year spent in appeal, the Court of Tribunal awarded Sue PIP ongoing for life."

Ocrelizumab licensed for people with early primary progressive MS in the UK

Blog post

Source MS Society:

Ocrelizumab has been approved as the first licensed treatment for some people with primary progressive MS in the UK.

Be kind to your mind

Blog post

Source MS Trust:

We often focus solely on our physical health but looking after our mental health is also vital to our sense of wellbeing. Jo Johnson, a consultant neuropsychologist with a special interest in MS, introduces practical steps you can take to improve and maintain your mental wellbeing.

Pages

Subscribe to Content labelled as: MS news